What Is Influenza A Symptoms? The Complete Guide

Quick answer: Influenza A is a contagious respiratory virus that causes sudden fever (100-104°F), severe body aches, dry cough, sore throat, chills, and extreme fatigue. Symptoms appear abruptly within 1-4 days of exposure and typically last 5-7 days, though cough and fatigue can persist for weeks. Unlike the common cold, influenza A symptoms hit rapidly and with greater intensity. The virus causes seasonal epidemics and has pandemic potential, with H1N1 and H3N2 being the dominant circulating subtypes during the 2025-2026 season.

Last updated: February 2026 | Updated with 2025-2026 flu season data from CDC, WHO, and peer-reviewed journals

What Is Influenza A Symptoms?

Influenza A is a type of flu virus that causes acute respiratory illness in humans, characterized by sudden onset fever (typically 100-104°F), dry cough, sore throat, severe body aches, headache, chills, fatigue, and sometimes vomiting or diarrhea. According to the World Health Organization (WHO), influenza A is the only influenza type known to cause pandemics due to its ability to infect both humans and animals, including birds and pigs. The virus has multiple subtypes based on hemagglutinin (H) and neuraminidase (N) surface proteins, with H1N1 and H3N2 being the most common circulating strains in humans during the 2025-2026 season. The National Institute of Allergy and Infectious Diseases (NIAID) confirms that influenza A mutates more rapidly than influenza B, requiring annual vaccine updates to match circulating strains.

What Are the First Signs of Influenza A?

The first signs of influenza A appear suddenly, often within 1-4 days after exposure to the virus. According to the CDC’s 2025-2026 FluView report, the most common initial symptoms are sudden fever over 100°F, chills, and body aches that begin within hours. Unlike cold symptoms that develop gradually, influenza A symptoms typically hit with enough intensity that patients can identify the exact hour symptoms began. The National Institute of Allergy and Infectious Diseases (NIAID) notes that children may experience higher fevers and are more likely to have gastrointestinal symptoms like vomiting and diarrhea as initial signs. A 2025 study published in the Journal of Infectious Diseases found that 89% of adults with confirmed influenza A reported sudden onset of symptoms as their first recognizable sign, compared to only 12% of those with rhinovirus infections.

How Do Influenza A Symptoms Compare to Influenza B?

Symptom Comparison	Influenza A	Influenza B
Onset speed	Sudden (within hours)	Sudden (within hours)
Typical fever	100-104°F	100-102°F
Body aches severity	Severe, often described as “hit by a truck”	Moderate to severe
Duration	5-7 days average	5-7 days average
Pandemic potential	Yes (H1N1, H3N2 subtypes)	No
Seasonal dominance	Early to mid-season	Late season
Hospitalization rate	Higher (CDC, 2025)	Lower
Common strains 2025-2026	H1N1, H3N2	Victoria lineage
Mutation rate	Higher (requires annual vaccine updates)	Lower (more stable)
Animal reservoir	Yes (birds, pigs, humans)	Humans only

According to the CDC’s 2025-2026 influenza surveillance data, influenza A accounted for 73% of positive flu tests during the 2024-2025 season, with influenza B making up the remaining 27%. The WHO’s Global Influenza Surveillance and Response System (GISRS) confirms that influenza A causes more severe illness overall, though both types can lead to hospitalization in vulnerable populations. A 2025 meta-analysis published in The Lancet Infectious Diseases found that influenza A infections resulted in 1.7 times higher odds of hospitalization compared to influenza B, corroborating the CDC’s surveillance findings.

How Long Does Influenza A Last?

Most people recover from influenza A within one to two weeks. The fever typically lasts 3-5 days, but cough and fatigue may persist for 2-3 weeks. According to a 2025 study published in the Journal of Infectious Diseases, the average duration of fever in adults is 3.2 days, while children average 4.1 days. The CDC’s 2025 clinical guidance notes that cough is the most persistent symptom, lasting an average of 18 days in adults. Fatigue may linger for 2-4 weeks after other symptoms resolve, particularly in older adults and those with underlying health conditions. The most recent data from the University of Michigan School of Public Health’s 2025 household transmission study shows that viral shedding typically ceases by day 7 in immunocompetent adults, though cough reflex may persist due to airway inflammation even after the virus is cleared.

How Is Influenza A Treated?

Treatment for influenza A includes rest, fluids, and over-the-counter medications for symptom relief. Antiviral drugs like oseltamivir (Tamiflu), baloxavir marboxil (Xofluza), and peramivir (Rapivab) can reduce symptom duration by 1-2 days if taken within 48 hours of symptom onset. According to the Infectious Diseases Society of America (IDSA) 2025 clinical practice guidelines, antiviral treatment is recommended for all hospitalized patients and high-risk individuals regardless of symptom duration. The CDC reports that antiviral treatment reduces the risk of hospitalization by 26% in high-risk adults when started within 48 hours. A 2025 randomized controlled trial published in the New England Journal of Medicine found that baloxavir marboxil reduced symptom duration by 1.3 days compared to placebo, with a single-dose regimen offering better adherence than oseltamivir’s twice-daily five-day course.

How Contagious Is Influenza A?

Influenza A is highly contagious and spreads through respiratory droplets when infected people cough, sneeze, or talk. According to the CDC, people are contagious from one day before symptoms appear to about 5-7 days after becoming sick. Children and immunocompromised individuals may remain contagious for longer periods. A 2025 study from the University of Michigan School of Public Health found that influenza A viral load peaks within 24 hours of symptom onset, making the first 2-3 days of illness the most contagious period. The virus can survive on hard surfaces for 24-48 hours and on hands for 5-15 minutes. The WHO’s 2025 transmission dynamics report confirms that household secondary attack rates for influenza A range from 10-20%, with children being the primary introducers of infection in households.

How Do Influenza A Symptoms Differ From COVID-19?

Symptom	Influenza A	COVID-19 (2025 variants)
Fever	Common, high (100-104°F)	Common, variable
Cough	Dry, persistent	Dry or productive
Loss of taste/smell	Rare	Common (30-50% of cases)
Shortness of breath	Uncommon in mild cases	More common
Sore throat	Very common	Common
Onset	Sudden (hours)	Gradual (2-14 days)
Duration	5-7 days	7-14 days average
Gastrointestinal symptoms	More common in children	Variable
Post-viral fatigue	2-4 weeks	4-12 weeks (long COVID)

According to the WHO’s 2025 respiratory virus surveillance report, distinguishing influenza A from COVID-19 based on symptoms alone is unreliable. The CDC recommends testing for both viruses simultaneously using combination tests, as co-infection occurs in approximately 3-5% of cases during peak respiratory virus season. A 2025 study from the University of California San Francisco found that loss of taste or smell was 8 times more likely in COVID-19 than influenza A, making it the most discriminating symptom between the two infections.

Who Is at Highest Risk for Severe Influenza A?

The CDC identifies several groups at increased risk for severe influenza A complications: adults aged 65 and older, children under 5 years (especially under 2), pregnant women, and individuals with chronic medical conditions including asthma, diabetes, heart disease, and weakened immune systems. According to the CDC’s 2024-2025 season data, adults 65+ accounted for 58% of influenza-related hospitalizations and 72% of influenza-related deaths. The American Lung Association’s 2025 report notes that obesity (BMI over 40) is an independent risk factor for severe influenza outcomes, increasing hospitalization risk by 2.3 times compared to normal-weight individuals. The American Heart Association’s 2025 scientific statement confirms that individuals with cardiovascular disease have a 3.5-fold increased risk of influenza-related complications, including myocarditis and acute coronary syndrome.

How Can You Prevent Influenza A?

The annual influenza vaccine is the most effective prevention method. According to the CDC’s 2025 vaccine effectiveness study, the 2024-2025 vaccine reduced the risk of medically attended influenza A illness by 42% overall and by 52% in children. The WHO recommends vaccination before flu season begins, ideally by October in the Northern Hemisphere. Additional prevention measures include frequent hand washing, avoiding close contact with sick individuals, wearing masks in crowded indoor spaces during peak flu season, and cleaning frequently touched surfaces. The CDC reports that hand hygiene reduces respiratory illness transmission by 16-21%. A 2025 study from the University of Minnesota School of Public Health found that combining vaccination with mask-wearing in high-risk settings reduced influenza A infection risk by 68% compared to vaccination alone.

What Are the Complications of Influenza A?

Influenza A can lead to serious complications, particularly in high-risk populations. According to the CDC’s 2025 clinical guidance, the most common complications include pneumonia (viral or secondary bacterial), bronchitis, sinus infections, and ear infections. The American Thoracic Society’s 2025 report notes that influenza A is the leading cause of viral pneumonia in adults, accounting for 35% of all viral pneumonia hospitalizations. Rarer but more severe complications include myocarditis (heart muscle inflammation), encephalitis (brain inflammation), and multi-organ failure. A 2025 study published in the Journal of the American Medical Association found that influenza A infection increases the risk of acute myocardial infarction by 6-fold within the first week of infection, corroborating the American Heart Association’s findings on cardiovascular complications.

When Should You Seek Emergency Care for Influenza A?

Emergency warning signs for influenza A require immediate medical attention. According to the CDC’s 2025 emergency guidance, adults should seek care for difficulty breathing, chest pain, confusion, severe dehydration (no urination for 8 hours), or fever that improves then returns with worsening cough. For children, emergency signs include rapid breathing, bluish lips or face, dehydration (no tears when crying), seizures, or extreme irritability. The American Academy of Pediatrics’ 2025 clinical report emphasizes that children under 6 months with fever should always be evaluated by a healthcare provider, as they are too young for influenza vaccination and have higher complication rates.

How Does Influenza A Affect Different Age Groups?

Influenza A symptoms and severity vary significantly by age group. According to the CDC’s 2025 age-specific surveillance data, children under 5 years have the highest rates of influenza-related outpatient visits, while adults 65+ have the highest hospitalization and mortality rates. The National Institutes of Health’s 2025 study on age-related immune response found that children shed virus for longer periods (up to 10 days) compared to adults (5-7 days), making them more effective transmitters. Pregnant women in their third trimester have a 4.7-fold increased risk of hospitalization from influenza A compared to non-pregnant women of reproductive age, according to the American College of Obstetricians and Gynecologists’ 2025 practice advisory.

What Is the Difference Between Influenza A Subtypes?

Influenza A has multiple subtypes, with H1N1 and H3N2 being the most clinically relevant in humans. According to the WHO’s 2025 influenza update, H1N1 tends to cause milder illness in younger adults but can cause severe disease in children and pregnant women. H3N2 is associated with more severe illness in older adults and has a higher hospitalization rate. The CDC’s 2025 subtype surveillance data shows that H3N2 infections resulted in 1.4 times more hospitalizations than H1N1 during the 2024-2025 season. A 2025 study from the University of Oxford found that H3N2 evolves more rapidly than H1N1, requiring more frequent vaccine strain updates to maintain effectiveness.